Hansen Medical (NSDQ:HNSN) said it completed a sale of 1 of its Sensei X robotic systems to the Maastricht University Medical Center in the Netherlands with help from Medtronic International (NYSE:MDT), a key partner to the Center.
The Sensei X Robotic system uses 3D catheter controls and 3D visualization to allow an operating surgeon to control its robotically steerable catheters for collecting electrophysiological data within the heart atria.
“Medtronic has been an outstanding partner throughout this commercial relationship at MUMC. Maastricht University Medical Center recognizes the impact of advanced robotic treatments for patients and is aligned with our strategic vision. We anticipate a growing relationship with MUMC as it continues its expansion as a world-class therapeutic and training center,” Hansen CEO Cary Vance said in a press release.
The Maastricth University Medical Center is a prominent European Therapeutic and training center, Hansen Medical said.
In November, Hansen Medical released its 3rd quarter earnings, blowing the street away on losses per share but missing on revenue, and announcing a new cost-reduction policy.
The company announced a cost reduction program that promises a lower break-even point of approximately $40 million, which it said will improve cash flow and allow for “further investment in new technology and new markets.”
The program will come with cuts to non-R&D staff, as well as a reduction in 3rd party services and “a more capital efficient facility location,” the company said.